Research page
1SG
Semaglutide

Specification
| Name | 1SG · Semaglutide |
|---|---|
| Catalog sizes | 10 mg |
| Adopted bacteriostatic water | 10 mg + 2.0 mL = 5 mg/mL |
Overview
1SG is semaglutide. It is TRACE’s catalog name for that peptide. Semaglutide is FDA-approved only as branded medicines. This vial is not that medicine.
Mechanism under study
Semaglutide is a GLP-1 analog. That literature studies satiety, gastric emptying, and glucose-dependent insulin secretion. This page does not carry those results over to a person.
What published research has reported
A phase 3 trial published in The New England Journal of Medicine in 2021 studied weekly semaglutide in adults with overweight or obesity, as a branded medicine. Those data do not transfer to this research vial.
Composition and mass
A 10 mg vial in the catalog. The adopted sheet uses 2 mL of bacteriostatic water (5 mg/mL).
Reconstitution
| mg | mL | mg/mL | |
|---|---|---|---|
| 10 | 2.0 | 5 | In the catalog |
Storage and handling
Lyophilized material cool, dry, and protected from light. Dissolved: 2–8 °C, not frozen, 28-day horizon.
Regulatory status
Approved semaglutide exists only as branded medicines. 1SG is semaglutide and is not that medicine. It is not a supplement or a food.